FindTrial
Sign In

Effects of inhaled nitric oxide used for lungs hypertension in critically ill patients.

Study of systemic and pulmonary hemodynamic effects of inahaled nitric oxide used for pulmonary arterial hypertension in critically ill patients. - Nitroccm

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/11/076879
Enrollment
12
Registered
2024-11-18
Start date
Unknown
Completion date
Unknown
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J984- Other disorders of lung

Interventions

Intervention1: Inhaled Nitric oxide: Continous inhaled nitric oxide via nitric oxide delivery device. Control Intervention1: NA: NA

Sponsors

Dr SUJEET RAI
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients of age 18-65 years of age admitted in ICU with pulmonary hypertension and left sided heart failure

Exclusion criteria

Exclusion criteria: Declined consent from guardian Patients with an increased bleeding risk (or) active bleeding due to vascular damage Allergic reaction to any drug Pregnancy and nursing period. Valvular heart disease

Design outcomes

Primary

MeasureTime frame
Determine the effect of nitric oxide on pulmonary and systemic circulation on patients admitted in ICUTimepoint: From the day of admission to next 72 hours.—

Secondary

MeasureTime frame
Determine the effect of nitric oxide on right heart failure in pulmonary hypertension patientsTimepoint: From the day of admission to next 72 hours.—

Countries

India

Contacts

Public ContactBrahamdutt sharma

Dr. RMLIMS LUCKNOW

drsujeetrai@gmail.com9161758940

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026